Robert Hoffman

Robert Hoffman

Director of Finance/CFO at CYTODYN INC.

Net worth: 8 400 $ as of 2026-08-30

60 year
Health Technology
Technology Services
Health Services

Profile

Robert E.
Hoffman
is currently Director at Day For Change, Independent Director at FibroBiologics, Inc. starting 2025, Director at TuHURA Biosciences, Inc. starting 2024, and Chief Financial & Accounting Officer at CytoDyn, Inc. starting 2025.
Former roles include Chairman, President, Chief Executive Officer & CFO at Kintara Therapeutics, Inc. from 2023 to 2024; Chairman at Antibe Therapeutics, Inc. from 2022 to 2024; Independent Director at Saniona AB from 2021 to 2022; Chief Financial Officer & Senior VP-Finance at Heron Therapeutics, Inc. from 2017 to 2020; Independent Director at Kura Oncology, Inc. from 2015 to 2021; Chief Financial Officer at AnaptysBio, Inc. from 2015 to 2016; Chief Financial & Accounting Officer, Executive VP at Innovus Pharmaceuticals, Inc. from 2016 to 2017; Independent Director at MabVax Therapeutics Holdings, Inc. from 2014 to 2017; Independent Director at CombiMatrix Corp.
from 2013 to 2017; President & Director at Financial Executives International of San Diego Chapter from 2010 to 2020; Chief Financial Officer at Polaris Group, Inc. in 2011; Chief Financial Officer & Senior VP-Finance at Arena Pharmaceuticals, Inc. from 2012 to 2015; Assistant Controller at Document Sciences Corp.
from 1994 to 1997; and Director or Independent Director roles at Telik, Inc., Zeta Acquisition Corp.
III, Aslan Pharmaceuticals Ltd., Versartis, Inc., ASLAN Pharmaceuticals Pte Ltd., and Esperion Therapeutics, Inc. Education includes an undergraduate degree from St. Bonaventure University conferred in 1988.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.01%
2026-06-25 3,641 ( 0.01% ) 7 755 $ 2026-08-30
2026-07-19 375 ( 0.01% ) 645 $ 2026-08-30

Robert Hoffman active positions

CompaniesPositionStart
FIBROBIOLOGICS, INC. Director/Board Member 2021-04-07
CYTODYN INC. Director of Finance/CFO 2025-05-14
Director/Board Member -

Former positions of Robert Hoffman

CompaniesPositionEnd
ESPERION THERAPEUTICS, INC. Director/Board Member 2026-07-12
KINTARA THERAPEUTICS, INC. Chief Executive Officer 2024-09-30
Director/Board Member 2024-07-16
ANTIBE THERAPEUTICS INC. Chairman 2024-04-23
SANA AB Director/Board Member 2022-05-24
See the detail of Robert Hoffman's experience

Training of Robert Hoffman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies24

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert Hoffman
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!